AMG 404 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ASP1951 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
- Status
- COMPLETED
- Phase
- PHASE2
A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- N/A
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CS1001 in Subjects with Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002)
- Status
- TERMINATED
- Phase
- PHASE1
KN046 in Subjects With Advanced Solid Tumors and Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of TP-3654 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1